Healthcare

Japan publishes generative-AI review framework for medical devices

Japan’s medical-device regulator published draft review criteria for products that use generative AI, creating a clearer compliance reference for developers.

Japan’s Pharmaceuticals and Medical Devices Agency published an English translation of draft review points for medical devices that use generative AI. The framework represents an explicit regulatory approach to generative-AI-enabled medical devices.

The guidance is relevant to manufacturers developing products that use generative models in clinical or medical-device contexts. It provides a reference point for how such products may be assessed before reaching the Japanese market.

The publication also has implications for international companies seeking market access in Japan. Developers will need to consider how generative systems are evaluated, documented and governed throughout product development.

The development matters because medical-device regulation is becoming more specific as generative AI moves into healthcare. Clear review criteria can support innovation, but they also raise compliance expectations for developers responsible for safety, performance and oversight.

Original source: OriginBrief

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI